A detailed history of Alliancebernstein L.P. transactions in Mannkind Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 274,550 shares of MNKD stock, worth $1.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
274,550
Previous 282,610 2.85%
Holding current value
$1.81 Million
Previous $1.48 Million 16.88%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.01 - $6.7 $40,380 - $54,002
-8,060 Reduced 2.85%
274,550 $1.72 Million
Q2 2024

Aug 14, 2024

BUY
$4.05 - $5.43 $113,845 - $152,637
28,110 Added 11.05%
282,610 $1.48 Million
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $15,402 - $27,387
5,100 Added 2.04%
254,500 $1.34 Million
Q1 2022

May 13, 2022

BUY
$2.62 - $4.45 $2,096 - $3,560
800 Added 0.32%
249,400 $918,000
Q3 2021

Nov 10, 2021

SELL
$3.89 - $5.48 $15,560 - $21,920
-4,000 Reduced 1.58%
248,600 $1.08 Million
Q2 2021

Jul 30, 2021

BUY
$3.61 - $5.45 $272,555 - $411,475
75,500 Added 42.63%
252,600 $1.38 Million
Q1 2021

May 06, 2021

SELL
$3.14 - $6.14 $149,150 - $291,650
-47,500 Reduced 21.15%
177,100 $694,000
Q4 2020

Feb 08, 2021

BUY
$1.79 - $4.04 $66,588 - $150,288
37,200 Added 19.85%
224,600 $703,000
Q3 2020

Nov 12, 2020

SELL
$1.56 - $2.08 $164,424 - $219,232
-105,400 Reduced 36.0%
187,400 $352,000
Q2 2020

Aug 13, 2020

BUY
$0.94 - $2.21 $30,174 - $70,941
32,100 Added 12.31%
292,800 $512,000
Q1 2020

May 14, 2020

BUY
$0.84 - $1.76 $51,576 - $108,064
61,400 Added 30.81%
260,700 $269,000
Q2 2019

Aug 14, 2019

BUY
$1.09 - $1.88 $94,285 - $162,620
86,500 Added 76.68%
199,300 $229,000
Q1 2019

May 14, 2019

SELL
$1.14 - $2.25 $47,651 - $94,050
-41,800 Reduced 27.04%
112,800 $222,000
Q3 2018

Nov 08, 2018

BUY
$1.01 - $2.19 $117,160 - $254,040
116,000 Added 300.52%
154,600 $283,000
Q2 2018

Aug 13, 2018

BUY
$1.59 - $2.38 $61,374 - $91,868
38,600 New
38,600 $73,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.7B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.